Figlioli G, Billaud A, Ahearn TU, Antonenkova NN, Becher H, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Blok MJ, Bogdanova NV, Bonanni B, Burwinkel B, Camp NJ, Campbell A, Castelao JE, Cessna MH, Chanock SJ, NBCS Collaborators, Czene K, Devilee P, Dörk T, Engel C, Eriksson M, Fasching PAet al.(2023) FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women Eur J Hum Genet(in press) DOI 10.1038/s41431-022-01257-w, PubMed 36707629
Normann LS, Haugen MH, Hongisto V, Aure MR, Leivonen SK, Kristensen VN, Tahiri A, Engebraaten O, Sahlberg KK, Mælandsmo GM(2023) High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer PLoS One, 18(1), e0280507 DOI 10.1371/journal.pone.0280507, PubMed 36706086
Mueller SH, Lai AG, Valkovskaya M, Michailidou K, Bolla MK, Wang Q, Dennis J, Lush M, Abu-Ful Z, Ahearn TU, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Aronson KJ, Augustinsson A, Baert T, Freeman LEB, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Blomqvist C, Bogdanova NV, Bojesen SEet al.(2023) Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry Genome Med, 15(1), 7 DOI 10.1186/s13073-022-01152-5, PubMed 36703164